AI Verdict
NEO has stronger fundamentals based on our AI analysis.
NERV vs NEO Fundamental Comparison
| Metric | NERV | NEO |
|---|---|---|
| Revenue | $0.0 | $727.3M |
| Net Income | $-293.4M | $-108.0M |
| Net Margin | N/A | -14.9% |
| ROE | N/A | -12.9% |
| ROA | -299.5% | -7.9% |
| Current Ratio | 36.28x | 4.26x |
| Debt/Equity | N/A | 0.41x |
| EPS | $-34.67 | $-0.21 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NERV vs NEO: Frequently Asked Questions
Is NERV or NEO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NEO has stronger fundamentals. NERV is rated STRONG SELL (85% confidence) while NEO is rated SELL (78% confidence). This is not investment advice.
How does NERV compare to NEO fundamentally?
Minerva Neurosciences, Inc. has ROE of N/A vs NEOGENOMICS INC's -12.9%. Net margins are N/A vs -14.9% respectively.
Which stock pays higher dividends, NERV or NEO?
NERV has a dividend yield of N/A or no dividend while NEO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NERV or NEO for long term?
For long-term investing, consider that NERV has STRONG SELL rating with 85% confidence, while NEO has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NERV vs NEO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NERV vs NEO, the AI consensus favors NEO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.